SVETLANA ISKHAKOVA: Open Payments
NPI 1356649321 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 50 payments from 15 companies in 2025. Trend: 2023 $617 · 2024 $742 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $239 |
| Amgen Inc. | 7 | $133 |
| Novartis Pharmaceuticals Corporation | 6 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $99 |
| Lilly USA, LLC | 3 | $60 |
| OPKO Pharmaceuticals, LLC | 3 | $49 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| Rhythm Pharmaceuticals, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Mannkind Corporation | 1 | $25 |
Products named: Ozempic, JARDIANCE, REPATHA, Wegovy, LEQVIO, MOUNJARO, RAYALDEE, NEXLETOL.
Industry payments across NY — which companies pay providers there.
